BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou L, Huntington K, Zhang S, Carlsen L, So EY, Parker C, Sahin I, Safran H, Kamle S, Lee CM, Geun Lee C, A Elias J, S Campbell K, T Naik M, J Atwood W, Youssef E, A Pachter J, Navaraj A, A Seyhan A, Liang O, El-Deiry WS. MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection. Oncotarget 2020;11:4201-23. [PMID: 33245731 DOI: 10.18632/oncotarget.27799] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Alexandrov V, Kirpich A, Kantidze O, Gankin Y. A multi-reference poly-conformational method for in silico design, optimization, and repositioning of pharmaceutical compounds illustrated for selected SARS-CoV-2 ligands. PeerJ 2022;10:e14252. [DOI: 10.7717/peerj.14252] [Reference Citation Analysis]
2 Oh CK, Nakamura T, Beutler N, Zhang X, Piña-Crespo J, Talantova M, Ghatak S, Trudler D, Carnevale LN, McKercher SR, Bakowski MA, Diedrich JK, Roberts AJ, Woods AK, Chi V, Gupta AK, Rosenfeld MA, Kearns FL, Casalino L, Shaabani N, Liu H, Wilson IA, Amaro RE, Burton DR, Yates JR 3rd, Becker C, Rogers TF, Chatterjee AK, Lipton SA. Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection. Nat Chem Biol 2022. [PMID: 36175661 DOI: 10.1038/s41589-022-01149-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Zheng X, Qiu J, Pan W, Gong Y, Zhang W, Jiang T, Chen L, Chen W, Hong Z. Selumetinib - a potential small molecule inhibitor for osteoarthritis treatment. Front Pharmacol 2022;13:938133. [DOI: 10.3389/fphar.2022.938133] [Reference Citation Analysis]
4 Sun Q, Li X, Kuang E. Subversion of autophagy machinery and organelle-specific autophagy by SARS-CoV-2 and coronaviruses. Autophagy 2022. [PMID: 36005882 DOI: 10.1080/15548627.2022.2116677] [Reference Citation Analysis]
5 Huntington KE, Carlsen L, So E, Piesche M, Liang O, El-deiry WS. Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity. Pharmaceuticals 2022;15:618. [DOI: 10.3390/ph15050618] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Rumienczyk I, Kulecka M, Statkiewicz M, Ostrowski J, Mikula M. Oncology Drug Repurposing for Sepsis Treatment. Biomedicines 2022;10:921. [DOI: 10.3390/biomedicines10040921] [Reference Citation Analysis]
7 Oh C, Nakamura T, Beutler N, Zhang X, Piña-crespo J, Talantova M, Ghatak S, Trudler D, Carnevale LN, Mckercher SR, Bakowski MA, Diedrich JK, Roberts AJ, Woods AK, Chi V, Gupta AK, Rosenfeld MA, Kearns FL, Casalino L, Shaabani N, Liu H, Wilson IA, Amaro RE, Burton DR, Yates JR, Becker C, Rogers TF, Chatterjee AK, Lipton SA. Targeted protein S-nitrosylation of ACE2 as potential treatment to prevent spread of SARS-CoV-2 infection.. [DOI: 10.1101/2022.04.05.487060] [Reference Citation Analysis]
8 Sertoglu E, Yucel C, Balık AR, Taşçı C, Bilge S, Ertuğrul MS, Nazaroğlu NK, Ozgurtas T. Evaluation of erythrocyte membrane fatty-acid compositions in association with interleukin-6 levels in patients with COVID-19. Nutrition 2022;96:111581. [DOI: 10.1016/j.nut.2021.111581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Salazar-garcía M, Acosta-contreras S, Rodríguez-martínez G, Cruz-rangel A, Flores-alanis A, Patiño-lópez G, Luna-pineda VM. Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019. Front Microbiol 2022;12:817200. [DOI: 10.3389/fmicb.2021.817200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Huntington KE, Carlsen L, So EY, Piesche M, Liang O, El-Deiry WS. Integrin/TGF-β1 inhibitor GLPG-0187 blocks SARS-CoV-2 Delta and Omicron pseudovirus infection of airway epithelial cells which could attenuate disease severity. medRxiv 2022:2022. [PMID: 35018385 DOI: 10.1101/2022.01.02.22268641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Cao J, Dong S, Liu Y, Zhou M, Guo J, Jia X, Zhang Y, Hou Y, Tian M, Xiao G, Wang W. Screening and Identification of Lujo Virus Entry Inhibitors From an Food and Drug Administration-Approved Drugs Library. Front Microbiol 2021;12:793519. [PMID: 34925303 DOI: 10.3389/fmicb.2021.793519] [Reference Citation Analysis]
12 Galganska H, Jarmuszkiewicz W, Galganski L. Carbon dioxide inhibits COVID-19-type proinflammatory responses through extracellular signal-regulated kinases 1 and 2, novel carbon dioxide sensors. Cell Mol Life Sci 2021;78:8229-42. [PMID: 34741187 DOI: 10.1007/s00018-021-04005-3] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Cao J, Liu Y, Dong S, Zhou M, Guo J, Jia X, Zhang Y, Hou Y, Xiao G, Wang W. Screening and Identification of Lujo Virus Entry Inhibitors from an FDA-Approved Drugs Library.. [DOI: 10.1101/2021.09.01.458657] [Reference Citation Analysis]
14 Chang C, Lee M, Lin B, Lu Y, Hsu Y, Chuang C, Huang T, Chen Y. The Effect of Azithromycin Plus Zinc Sulfate on ACE2 Expression through IκBα of Human Respiratory Cells in SARS-CoV-2: In Vitro Study. COVID 2021;1:263-275. [DOI: 10.3390/covid1010021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Lucchetta M, Pellegrini M. Drug Repositioning by Merging Active Subnetworks Validated in Cancer and COVID-19.. [DOI: 10.1101/2021.05.13.21257140] [Reference Citation Analysis]
16 Abid MB. Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations. J Immunother Cancer 2021;9:e002307. [PMID: 33931473 DOI: 10.1136/jitc-2020-002307] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
17 O'Donovan SM, Imami A, Eby H, Henkel ND, Creeden JF, Asah S, Zhang X, Wu X, Alnafisah R, Taylor RT, Reigle J, Thorman A, Shamsaei B, Meller J, McCullumsmith RE. Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach. Sci Rep 2021;11:4495. [PMID: 33627767 DOI: 10.1038/s41598-021-84044-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
18 Huntington KE, Louie AD, Lee CG, Elias JA, Ross EA, El-Deiry WS. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2. Elife 2021;10:e64958. [PMID: 33443016 DOI: 10.7554/eLife.64958] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
19 Huntington KE, Louie AD, Lee CG, Elias JA, Ross EA, El-Deiry WS. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients with COVID-19. medRxiv 2020:2020. [PMID: 33269361 DOI: 10.1101/2020.11.24.20235721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]